tiprankstipranks
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Hong Kong Market
2696
Shanghai Henlius Biotech, Inc. Class H
RESEARCH TOOLSreports

Shanghai Henlius Biotech, Inc. Class H (2696) Revenue

7 Followers
StatisticsMarket CapRevenue

Shanghai Henlius Biotech, Inc. Class H Revenue

Shanghai Henlius Biotech, Inc. Class H had a revenue of 1.41B in the quarter ending Jun 30, 2025, with 0.00%. This bring the company's revenue in the last twelve months to 5.80B, Decreased 0.64%. In the fiscal year ending Dec 31, 2024, Shanghai Henlius Biotech, Inc. Class H had annual revenue of 5.72B with 6.11% growth.
Revenue (ttm)
5.80B
Revenue Growth
2.57%
P/S Ratio
7.52
Revenue/Employee
HK$1,628,577
Employees
3,515
Market Cap
HK$43.07B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
5.72B329.54M+6.11%
Dec 31, 2023
5.39B2.18B+67.82%
Dec 31, 2022
3.21B1.53B+91.07%
Dec 31, 2021
1.68B1.09B+186.34%
Dec 31, 2020
587.59M496.66M+546.20%
Dec 31, 2019
90.93M83.51M+1,125.29%
Dec 31, 2018
7.42M-26.49M-78.12%
Dec 31, 2017
33.91M――